A Randomized Study of Whether Alfuzosin(Xatral) Helps in the Passage of Kidney Stones
Status:
Withdrawn
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
Patients who present for the first time to Emergency Room with renal colic due to a distal
ureteral calculus (as diagnosed with spiral CT scan and KUB) will be randomized to receive
Xatral 10mg po once a day or placebo once discharged from the ER. The purpose of this study
is to assess if patients treated with Xatral will have a higher spontaneous passage rate of
their ureteral stone than those treated with placebo.
Phase:
N/A
Details
Lead Sponsor:
St. Michael's Hospital, Toronto Unity Health Toronto